Logo image
Back
Usefulness of pindolol for treatment of neurocardiogenic syncope
Journal article   Peer reviewed

Usefulness of pindolol for treatment of neurocardiogenic syncope

Nandini Nair, Farooq A Padder, Steven P Kutalek and Bharat K Kantharia
The American journal of cardiology, v 94(9), pp 1189-1191
01 Nov 2004
DOI: https://doi.org/10.1016/j.amjcard.2004.07.093
PMID: 15518620
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Adolescent Adrenergic beta-Antagonists - therapeutic use Adult Age Factors Aged Aged, 80 and over Blood Pressure - drug effects Drug Evaluation Female Follow-Up Studies Heart Rate - drug effects Humans Male Middle Aged Pindolol - therapeutic use Syncope, Vasovagal - drug therapy Tilt-Table Test Treatment Outcome
This study evaluated the efficacy of pindolol, a noncardioselective beta blocker with intrinsic sympathetic activity, on neurocardiogenic syncope using a head-up tilt-table test in 66 patients. Pindolol was equally effective in men and women and the 2 age groups (>60 and <60 years) of the study cohort. The earliest benefit was seen </=3 days after initiating treatment. Side effects were better tolerated in younger patients (age <60 years).

Metrics

14 Record Views
11 citations in Web of Science
11 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Logo image